YARROW BIOSCIENCE, INC. Increase (Decrease) in Accrued Liabilities
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Accrued Liabilities of -$44.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-12-31 was $473.00K, a 47.44% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-09-30 was -$763.00K, a 142.11% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-06-30 was $333.00K, a 15.05% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for the quarter ending 2019-03-31 was -$87.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for fiscal 2019 was -$44.00K, a 101.62% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for fiscal 2018 was $2.72M, a 8.64% decline from fiscal 2017.
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for fiscal 2017 was $2.98M, a 538.63% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. increase (decrease) in accrued liabilities for fiscal 2016 was $466.00K, a 34.68% increase from fiscal 2015.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $473.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$290.00K derived: sum of 2 quarters · filed 2020-03-03 | $43.00K derived: sum of 3 quarters · filed 2020-03-03 | -$44.00K 10-K · filed 2020-03-03 |
| 2019-09-30 | -$763.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$430.00K derived: sum of 2 quarters · filed 2019-10-31 | -$517.00K 10-Q · filed 2019-10-31 | $383.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-06-30 | $333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $246.00K 10-Q · filed 2019-08-01 | $1.15M derived: sum of 3 quarters · filed 2020-03-03 | $2.96M derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-03-31 | -$87.00K 10-Q · filed 2019-05-02 | $813.00K derived: sum of 2 quarters · filed 2020-03-03 | $2.63M derived: sum of 3 quarters · filed 2020-03-03 | $3.02M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $2.71M derived: sum of 2 quarters · filed 2020-03-03 | $3.10M derived: sum of 3 quarters · filed 2020-03-03 | $2.72M 10-K · filed 2020-03-03 |
| 2018-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.20M derived: sum of 2 quarters · filed 2019-10-31 | $1.82M 10-Q · filed 2019-10-31 | $3.48M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | $392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $7.00K 10-Q · filed 2019-08-01 | $1.66M derived: sum of 3 quarters · filed 2020-03-03 | -$2.96M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | -$385.00K 10-Q · filed 2019-05-02 | $1.27M derived: sum of 2 quarters · filed 2020-03-03 | -$3.35M derived: sum of 3 quarters · filed 2020-03-03 | $2.31M derived: sum of 4 quarters · filed 2020-03-03 |
| 2017-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$2.96M derived: sum of 2 quarters · filed 2020-03-03 | $2.70M derived: sum of 3 quarters · filed 2020-03-03 | $2.98M 10-K · filed 2020-03-03 |
| 2017-09-30 | -$4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.04M derived: sum of 2 quarters · filed 2018-11-07 | $1.32M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $5.94M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $278.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $466.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $346.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |